| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21922-020-12 | 21922-020 | HUMAN PRESCRIPTION DRUG | Tavaborole | TAVABOROLE topical solution, 5% | SOLUTION | TOPICAL | 20201019 | N/A | ANDA | ANDA211297 | Encube Ethicals Private Limited | TAVABOROLE | 43.5 mg/mL | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (21922-020-12) / 10 mL in 1 BOTTLE, WITH APPLICATOR |
| 51862-690-10 | 51862-690 | HUMAN PRESCRIPTION DRUG | tavaborole | tavaborole | SOLUTION | TOPICAL | 20210201 | 20250531 | ANDA | ANDA211297 | Mayne Pharma Commercial LLC | TAVABOROLE | 43.5 mg/mL | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (51862-690-10) / 10 mL in 1 BOTTLE, WITH APPLICATOR |